Personnel

Cytogen appoints Kevin Bratton new chief financial officer

Published in Cancer Law Weekly, November 25th, 2006

Cytogen Corporation (CYTO) announced the appointment of Kevin Bratton as the company's new chief financial officer.

A finance executive with more than 35 years of experience in healthcare, biotechnology and technology, Bratton was previously chief financial officer at Metrologic Instruments, Inc. (MTLG), a global technology company. During his tenure at Metrologic, Bratton directed the company's finance operations during a period of significant growth in sales, net income, cash flow from operations, and working capital.

"With the recent addition of two marketed oncology products, Soltamox and Caphasol, our business is poised for substantial growth...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Law Weekly

Source: Cancer Law Weekly (2006-11-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry